skip to main content

ESSPRI Patient Symptoms Sjogren — SCE Rheumatology MCQ

Instant feedback + full explanation. One question, done properly.

HardConnective Tissue DiseaseESSPRI Patient Symptoms SjogrenSCE Rheumatology

A 55-year-old woman with primary Sjogren syndrome on HCQ has a ESSPRI score of 8 (out of 10). What does ESSPRI measure?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: DESSPRI (EULAR Sjogren Syndrome Patient Reported Index) measures patient-reported symptoms: dryness fatigue and pain on 0-10 scales capturing the symptom burden from the patient perspective

The best answer is “ESSPRI (EULAR Sjogren Syndrome Patient Reported Index) measures patient-reported symptoms: dryness fatigue and pain on 0-10 scales capturing the symptom burden from the patient perspective”. ESSPRI (EULAR Sjogren Syndrome Patient Reported Index) measures patient-reported symptoms: dryness fatigue and pain on 0-10 scales capturing the symptom burden from the patient perspective is supported by the cited UK or directly applicable specialist authority and best matches the tested threshold, complication or monitoring principle. The remaining choices—“principally salivary flow, after specialist assessment, after specialist assessment, with clinical reassessment, within a rheumatology pathway, after safety review, after specialist assessment, with clinical reassessment”, “Physician assessment of disease, with clinical reassessment, within a rheumatology pathway, after safety review, after specialist assessment, with clinical reassessment, within a rheumatology pathway”, “principally tear production, within a rheumatology pathway, within a rheumatology pathway, after safety review, after specialist assessment, with clinical reassessment, within a rheumatology pathway”, “Systemic organ involvement, after safety review, after safety review, after specialist assessment, with clinical reassessment, within a rheumatology pathway, after safety review, after specialist assessment”—are credible in related rheumatology presentations, but each addresses a different diagnosis, investigation, treatment sequence or complication and does not fit the decisive findings in this stem.

Reference: BSR guideline on Sjögren disease: https://academic.oup.com/rheumatology/article/64/2/409/7645909